Condition
High-grade Squamous Intraepithelial Lesion (HSIL) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 High-grade Squamous Intraepithelial Lesion (HSIL) clinical trials that are recruiting, in China. By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
NWRD08 for HPV‑16/18‑related cervical HSIL (CIN2/3)
This trial tests whether injections of NWRD08 given with electroporation can help women aged 18–60 who have HPV‑16 or HPV‑18 positive cervical high‑grade lesions (CIN2 or CIN3).
-
NWRD09 mRNA vaccine for HPV16-related cervical HSIL
This Phase 1 study will try an mRNA vaccine called NWRD09 to see if it is safe and triggers immune responses in people with HPV16-related cervical HSIL.
Quick answers
How many High-grade Squamous Intraepithelial Lesion (HSIL) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.